Dear INS Members,
On the heels of the official site visit for the International Neuromodulation Society’s (INS) 2017 Congress in Edinburgh, Scotland, I am excited to tell you that Edinburgh truly is a strikingly beautiful and unforgettable place. Together with members of the INS Executive Committee, Drs. Robert Levy and Simon Thomson, as well as with Mr. Roger Strachan, and Drs. Ganesan Baranidharan and Ashish Gulve from the Local Organizing Committee and UK and Ireland Chapter (NSUKI), we explored the city from its cobble-stoned Royal Mile up to Edinburgh Castle, to the state-of-the-art Edinburgh International Conference Center (EICC), and have come away inspired, knowing that Edinburgh offers the perfect mix of cultural wealth and innovation, and thus is the ideal venue for the INS’s 13th World Congress. We cannot wait to share it with you!
Steeped in history and once hailed as the Athens of the North, Edinburgh has been home to enlightened writers, philosophers and physicians -- including two pioneers of early surgical technique: Sir Joseph Lister, who championed the use of carbolic acid as an antiseptic; and Sir James Young Simpson, who discovered the anesthetic properties of chloroform in surgery. A more recent alumnus of the University of Edinburgh’s medical school, Mr. Roger Strachan -- President of NSUKI, generously shared with us his insider’s perspective and insights as we toured the grand Royal College of Surgeons, the likely venue for our hands-on cadaver workshop.
The main congress will take place in the heart of Edinburgh at the EICC, a cutting-edge conference center with ample room for the INS to increase its scientific offerings and better serve our members’ and commercial supporters’ needs, while maintaining the intimacy that is vital to nurturing communication and collaboration in our society.
The EICC is within walking distance of the main tourist attractions and many hotels (suiting a wide range of budgets), the closest being the newly refurbished Sheraton Grand Hotel and Spa, which is only a few meters away and will host most of the congress’s ancillary events. The EICC and Sheraton staff and all the locals we met during our visit were extremely knowledgeable and eager to please as they very much look forward to hosting us in their magnificent city.
I was also excited to learn that the Edinburgh Marathon is scheduled for the 28th of May, so we may plan some INS-related events around the marathon for our athletic delegates.
Please stay tuned as more details unfold. In the meantime, I would like to thank Mr. Strachan, and Drs. Baranidharan, Gulve, Levy and Thomson, along with Annika Hayes, our meeting planner at Vanern Enterprises, who made all the arrangements with her local contacts, for joining in the site visit and setting the wheels in motion for an excellent and memorable congress. I hope we have inspired you to join us in Edinburgh!
Timothy R. Deer, MD
New! INS is Now Accepting Panelist Applications for "Innovations in Neuromodulation"
The International Neuromodulation Society is pleased to announce "Innovations in Neuromodulation," its fourth educational event for the neuromodulation innovation and investment community, which will take place on 28 May 2017, in Edinburgh, Scotland, as part of the official pre-conference of the INS 13th World Congress. (Note: The date has changed from 27th May to 28th May 2017.) This unique event will bring together over 200 leaders in the global neuromodulation and investment communities to share the wealth of their experiences, and their visions for the future of this exciting and rapidly evolving field.
The theme of this event will be “The Challenge of Reimbursement: Can we do this Smarter?” with the aim of achieving several objectives:
• Identify and discuss the data that needs to be collected by commercialising companies to ensure it has utility for future reimbursement applications.
• Learn about the process by which innovations occur, become funded, receive reimbursement and reach the marketplace.
• Describe the process of establishing and protecting intellectual property.
• Define the regulatory process by which the CE Mark and FDA approval are obtained in Europe and in the U.S., respectively, and ultimately earn full reimbursement.
• Learn about what public scientific initiatives are available with which to partner
• Find out about current and future investment strategies and challenges in the device market --both in Europe and in the U.S.
• Discover emerging companies and the science behind their innovative therapies.
• Network with the leaders in innovation, investment, basic science and clinical practice in the neuromodulation space.
INS is presenting an opportunity for innovators to share their company stories with venture capitalists, clinicians, engineers and other Industry members. We invite entrepreneurs and startup companies who wish to participate in our emerging company panel to submit their applications by 22nd December 2016.
Please feel free to contact the INS Executive Office with any questions about participating in the pre-conference or exhibiting in the main congress.
We hope to see you in Edinburgh!
Dr. Simon Thomson,
INS Immediate Past-President
Co-Chair, INS Scientific Committee and Innovations in Neuromodulation
Dr. Marc Russo
Co-Chair, Innovations in Neuromodulation
Dr. Jeffrey Arle
Dr. Philippe Rigoard
Dr. Konstantin Slavin
Previous INS Congresses
Giant in Neuromodulation Awards
Future INS and Chapter events can be found under "Events", also view individual Chapter Pages for information.
Previous Congress Supporters & Exhibitors
Continuing Medical Education
This activity is being planned and implemented in accordance with the Essential Areas and policies of the European and American Accreditation Councils for Continuing Medical Education, and shall provide continuing medical education for physicians.
CME Mission Statement
The International Neuromodulation Society promotes improvement in patient health care by providing physicians and allied health care professionals with high quality, evidence-based educational activities focusing on advances in the field of neuromodulation; basic, translational and clinical research; new technology; and global health care. The overarching goals are to enhance learners’ knowledge, competence and performance to improve patient access, selection, safety and clinical outcomes.
Edinburgh International Conference Centre (EICC)
The Exchange Edinburgh
Edinburgh EH3 8EE Scotland
Book your hotel reservation through the Congress registration system. There are several hotel options available, all within close proximity to the EICC. For accommodation questions, please contact congress organizer and registrar, Vanern Enterprises.